Summary: Featuring articles on pembrolizumab for advanced urothelial cancer, temozolomide plus radiotherapy in glioblastoma, induced pluripotent stem-cell-based transplantation, vision loss and intravitreal "stem-cell" injection, lessons from Oregon about end-of-life care, and induced rejuvenation; a review article on acute lower gastrointestinal bleeding; a case report of a Zimbabwean man with a severe headache; and Perspective articles on per capita caps in Medicaid, on clarifying stem-cell therapy's benefits and risks, on improving hospital incentives with better cost data, and on another senseless death.
